Teva Pharma (TEVA) Reports Top-Line Results from GALA Phase III Trial for Glatiramer Acetate, Says Data Met Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/19/2026

1. NFLX
2. ISRG
3. SPY
4. USB
5. AAPL
6. NVDA
7. SPCX
8. BA
9. GCTK
10. CFG

Go back to Teva Pharma (TEVA) Reports Top-Line Results from GALA Phase III Trial for Glatiramer Acetate, Says Data Met Primary Endpoint